125742 S2 M1 hospira diluent label

Pfizer Documents (PHMPT/FDA)

Pfizer Bla Submission

Pfizer 16 Plus Documents

1

Document text

Diluent For Use with
[COVID-19 mRNA Vaccine
(nucleoside modified)] 
COMIRNATYTM
COMDILRMComirnaty Diluent Label           2P      May 10, 2021     am
Black
1.25” x 2.75”Comirnaty Diluent Label_2.pdf   1   5/10/21   4:41 PM
090177e197028df4\Approved\Approved On: 11-May-2021 20:52 (GMT)
FDA-CBER-2021-5683-0225031